SearchDictionaryMobileLogin

William K Oh Selected Research

Hormones

05/2008A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.
02/2008Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer.
02/2008A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel.
12/2007Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.
03/2007The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.
03/2007Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.
02/2007Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
06/2006Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes.
06/2005Response to docetaxel/carboplatin in patients with hormone-refractory prostate cancer not responding to taxane-based chemotherapy.
12/2003A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.

Articles by Research Topic

Disease

39Prostatic Neoplasms (Prostate Cancer)
10/2008 - 02/2002
5Carcinoma (Carcinomatosis)
10/2004 - 02/2002
3Neoplasm Metastasis (Metastasis)
12/2007 - 03/2007
3Neoplasms (Cancer)
09/2004 - 01/2002
1Ulcer
11/2006
1Gynecomastia
06/2006
1Seminoma
06/2006
1Abscess
05/2006
1Leukemia
12/2003
1Testicular Neoplasms (Testicular Cancer)
08/2003

Drug/Important Bio-Agent (IBA)

10HormonesIBA
05/2008 - 12/2003
6docetaxel (Taxotere)FDA Link
09/2008 - 12/2003
6Prostate-Specific Antigen (Semenogelase)IBA
03/2008 - 02/2002
5Carboplatin (JM8)FDA LinkGeneric
02/2008 - 12/2003
3EstramustineFDA Link
03/2007 - 12/2003
3herbal preparation PC-SPESIBA
09/2004 - 02/2002
2Estrogens (Estrogen)FDA Link
06/2007 - 09/2002
2zoledronic acid (zoledronate)FDA Link
03/2007 - 08/2006
1AdiponectinIBA
10/2008
1Mifepristone (RU 486)FDA Link
05/2008
1Alkaline PhosphataseIBA
12/2007
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2007
1vinorelbine (Navelbine)FDA LinkGeneric
03/2007
1PlatinumIBA
02/2007
1OxygenIBA
11/2006
1Ketoconazole (Nizoral)FDA LinkGeneric
09/2006
1atrasentanIBA
08/2006
1celecoxib (Celebrex)FDA Link
06/2006
1bicalutamide (Casodex)FDA Link
06/2006
1Mitoxantrone (Novantrone)FDA LinkGeneric
06/2006
1TaxoidsIBA
06/2006
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2006
1imatinib (Gleevec)FDA Link
01/2006
1nilutamide (Nilandron)FDA Link
10/2005
1taxaneIBA
06/2005
1epothilone B (EPO906)IBA
03/2005
1ixabepilone (BMS 247550)FDA Link
03/2005
1rosiglitazone (Avandia)FDA Link
10/2004
1Diethylstilbestrol (Stilbestrol)FDA Link
09/2004
1gemcitabineFDA Link
09/2004
1Paclitaxel (Taxol)FDA LinkGeneric
09/2004
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
06/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2004
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2003
1Flutamide (Eulexin)FDA LinkGeneric
07/2003
1Finasteride (Propecia)FDA LinkGeneric
07/2003
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2003
1Aromatase (CYP19)IBA
11/2002
1Interferon-alpha (Interferon Alfa)FDA Link
01/2002
1Toremifene (Fareston)FDA Link
01/2002

Therapy/Procedure

13Drug Therapy (Chemotherapy)
09/2008 - 05/2003
5Prostatectomy (Retropubic Prostatectomy)
06/2006 - 05/2003
4Castration
09/2008 - 07/2003
2Neoadjuvant Therapy
05/2003 - 05/2003
1Adjuvant Chemotherapy
10/2004
1Lymph Node Excision (Lymph Node Dissection)
08/2003
1Complementary Therapies (Alternative Medicine)
12/2002
1Phytotherapy (Herbal Therapy)
02/2002